06:33:35 Europe / Stockholm

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Prenumeration

Kalender

2025-06-03 Årsstämma
2025-02-28 Bokslutskommuniké 2024
2024-08-28 Kvartalsrapport 2024-Q2
2024-06-07 X-dag ordinarie utdelning LIPI 0.00 SEK
2024-06-05 Årsstämma
2024-05-21 Extra Bolagsstämma 2024
2024-02-28 Bokslutskommuniké 2023
2023-11-22 Kvartalsrapport 2023-Q3
2023-08-23 Kvartalsrapport 2023-Q2
2023-06-09 X-dag ordinarie utdelning LIPI 0.00 SEK
2023-06-08 Årsstämma
2023-05-11 Kvartalsrapport 2023-Q1
2023-02-22 Bokslutskommuniké 2022
2023-01-17 Extra Bolagsstämma 2022
2022-11-23 Kvartalsrapport 2022-Q3
2022-08-24 Kvartalsrapport 2022-Q2
2022-06-03 X-dag ordinarie utdelning LIPI 0.00 SEK
2022-06-02 Årsstämma
2022-05-05 Kvartalsrapport 2022-Q1
2022-02-23 Bokslutskommuniké 2021
2021-11-25 Kvartalsrapport 2021-Q3
2021-08-24 Kvartalsrapport 2021-Q2
2021-06-09 X-dag ordinarie utdelning LIPI 0.00 SEK
2021-06-08 Årsstämma
2021-06-08 Extra Bolagsstämma 2021
2021-05-06 Kvartalsrapport 2021-Q1
2021-02-23 Bokslutskommuniké 2020
2020-11-26 Kvartalsrapport 2020-Q3
2020-08-27 Kvartalsrapport 2020-Q2
2020-08-11 Extra Bolagsstämma 2020
2020-06-12 X-dag ordinarie utdelning LIPI 0.00 SEK
2020-06-11 Årsstämma
2020-05-19 Kvartalsrapport 2020-Q1
2020-02-25 Bokslutskommuniké 2019
2019-11-21 Kvartalsrapport 2019-Q3

Beskrivning

LandSverige
ListaFirst North Stockholm
SektorHälsovård
IndustriLäkemedel & Handel
Lipidor är verksamt inom läkemedelsbranschen. Bolaget arbetar med forskning och utveckling inom preklinisk samt klinisk fas. Störst affärsverksamhet återfinns inom utveckling av läkemedel som vidare används för behandling av diverse hudsjukdomar. Exempel på sjukdomar som behandlas inkluderar exempelvis psoriasis, olika hudinfektioner samt atopisk dermatit. Huvudkontoret ligger i Solna.
2022-08-25 14:30:00

STOCKHOLM, Sweden, 25 August 2022 – Lipidor AB (publ) (Nasdaq First North Growth Market: LIPI) announces today that Charlotta Ekman has been appointed new Chief Financial Officer of Lipidor. In the role of CFO, Charlotta will also be part of Lipidor's management team. She will take office on 1st October.

Charlotta Ekman has broad experience from senior positions as CFO and COO at development and growth companies such as Minesto AB and Acosense AB. Most recently, she comes from a self-employed consulting role in business and operational development where, among other things, she has had a consulting assignment at Lipidor since November 2021. Charlotta is a trained economist and has a degree from Chalmers School of Entrepreneurship.

In addition to responsibility for Lipidor's finance functions, there will be an emphasis in the work on strategy implementation, organization and management, in close collaboration with the company's CEO.

"Charlotta has a solid background and experience with B2B companies in the growth phase of an international market,” says Ola Holmlund, Lipidor CEO. “She will have an important operational and strategic role in the company, given the company's ambitions and agenda. It makes her a perfect fit for Lipidor and we are very happy to welcome her to us."

Holmlund adds: “I would also like to take this opportunity to thank our outgoing CFO Michael Owens for his excellent collaboration during these years. Michael has been a great support in complex issues and not least in Lipidor's IPO.”

Publication

The information was provided for publication by Lipidor’s CEO on 25 August 2022 at 2.30pm CEST.